Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNX NASDAQ:CVRX NASDAQ:NPCE NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$13.89+11.6%$10.83$8.80▼$32.71$618.94M3.41.14 million shs1.32 million shsCVRXCVRx$5.87+8.8%$7.21$4.37▼$11.30$155.68M0.8341,933 shs310,408 shsNPCENeuroPace$16.32+2.8%$15.81$7.56▼$19.60$556.35M1.88207,581 shs184,475 shsTCMDTactile Systems Technology$25.17+3.3%$24.73$9.41▼$37.77$567.84M0.83334,666 shs224,216 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics-2.69%+7.02%+20.95%+12.03%-30.70%CVRXCVRx-0.74%-6.75%-32.37%-35.60%-20.27%NPCENeuroPace-2.52%-6.92%-6.97%+16.76%+17.28%TCMDTactile Systems Technology-0.16%-2.79%+6.47%-17.14%+137.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$13.89+11.6%$10.83$8.80▼$32.71$618.94M3.41.14 million shs1.32 million shsCVRXCVRx$5.87+8.8%$7.21$4.37▼$11.30$155.68M0.8341,933 shs310,408 shsNPCENeuroPace$16.32+2.8%$15.81$7.56▼$19.60$556.35M1.88207,581 shs184,475 shsTCMDTactile Systems Technology$25.17+3.3%$24.73$9.41▼$37.77$567.84M0.83334,666 shs224,216 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics-2.69%+7.02%+20.95%+12.03%-30.70%CVRXCVRx-0.74%-6.75%-32.37%-35.60%-20.27%NPCENeuroPace-2.52%-6.92%-6.97%+16.76%+17.28%TCMDTactile Systems Technology-0.16%-2.79%+6.47%-17.14%+137.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.64Moderate Buy$19.7041.83% UpsideCVRXCVRx 3.00Buy$11.5096.05% UpsideNPCENeuroPace 2.88Moderate Buy$18.8315.40% UpsideTCMDTactile Systems Technology 2.86Moderate Buy$38.6053.36% UpsideCurrent Analyst Ratings BreakdownLatest CVRX, BBNX, NPCE, and TCMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2026BBNXBeta Bionics The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$19.00 ➝ $17.005/21/2026TCMDTactile Systems Technology BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$40.005/18/2026BBNXBeta Bionics Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$23.00 ➝ $11.005/15/2026NPCENeuroPace HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$19.00 ➝ $20.005/7/2026TCMDTactile Systems Technology B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$32.00 ➝ $36.005/6/2026CVRXCVRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/6/2026TCMDTactile Systems Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C-)5/5/2026TCMDTactile Systems Technology BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$38.00 ➝ $40.004/22/2026BBNXBeta Bionics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$25.00 ➝ $24.004/22/2026BBNXBeta Bionics Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$22.00 ➝ $20.004/21/2026BBNXBeta Bionics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 6/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$100.25M6.17N/AN/A$6.53 per share2.13CVRXCVRx$56.65M2.75N/AN/A$1.50 per share3.91NPCENeuroPace$99.99M5.56N/AN/A$0.57 per share28.63TCMDTactile Systems Technology$329.52M1.72$1.19 per share21.19$9.80 per share2.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta Bionics-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/ACVRXCVRx-$53.31M-$2.02N/AN/AN/A-89.14%-120.76%-48.38%8/4/2026 (Estimated)NPCENeuroPace-$21.47M-$0.65N/AN/AN/A-21.67%-108.20%-18.50%8/11/2026 (Estimated)TCMDTactile Systems Technology$19.09M$0.8828.6017.36N/A5.91%9.70%7.53%8/3/2026 (Estimated)Latest CVRX, BBNX, NPCE, and TCMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026NPCENeuroPace-$0.19-$0.13+$0.06-$0.20$21.65 million$22.00 million5/11/2026Q1 2026CVRXCVRx-$0.51-$0.50+$0.01-$0.50$14.49 million$14.77 million5/4/2026Q1 2026TCMDTactile Systems Technology-$0.07-$0.08-$0.01-$0.08$70.57 million$75.27 million4/21/2026Q1 2026BBNXBeta Bionics-$0.53-$0.49+$0.04-$0.49N/A$27.63 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/ACVRXCVRxN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/A10.699.67CVRXCVRx2.0110.208.89NPCENeuroPace4.085.384.35TCMDTactile Systems TechnologyN/A4.243.78Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/ACVRXCVRx75.27%NPCENeuroPace78.83%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipBBNXBeta Bionics5.30%CVRXCVRx13.90%NPCENeuroPace20.50%TCMDTactile Systems Technology2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29444.56 million42.20 millionN/ACVRXCVRx16026.54 million22.85 millionOptionableNPCENeuroPace17034.09 million27.11 millionOptionableTCMDTactile Systems Technology1,08622.56 million22.08 millionOptionableCVRX, BBNX, NPCE, and TCMD HeadlinesRecent News About These CompaniesTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 3 at 2:04 AM | americanbankingnews.comTactile Medical Launches Next-Generation AffloVest® Airway Clearance TherapyJune 2 at 8:00 AM | globenewswire.comTactile Systems Technology, Inc. $TCMD Shares Purchased by LSV Asset ManagementMay 26, 2026 | marketbeat.comBTIG Remains a Buy on Tactile Systems Technology (TCMD)May 23, 2026 | theglobeandmail.comBTIG Research Reiterates Buy Rating for Tactile Systems Technology (NASDAQ:TCMD)May 21, 2026 | marketbeat.comUBS Group AG Sells 168,372 Shares of Tactile Systems Technology, Inc. $TCMDMay 21, 2026 | marketbeat.comTactile Medical to Present at the William Blair 46th Annual Growth Stock ConferenceMay 20, 2026 | globenewswire.comVanguard Group Inc. Boosts Position in Tactile Systems Technology, Inc. $TCMDMay 17, 2026 | marketbeat.comElaine Birkemeyer Sells 4,631 Shares of Tactile Systems Technology (NASDAQ:TCMD) StockMay 14, 2026 | insidertrades.com52,740 Shares in Tactile Systems Technology, Inc. $TCMD Bought by RFG Advisory LLCMay 9, 2026 | marketbeat.comB Riley Securities upgrades Tactile Systems Technology (TCMD)May 8, 2026 | msn.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 8, 2026 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkMay 7, 2026 | finance.yahoo.comTactile Systems Technology (NASDAQ:TCMD) Upgraded by B. Riley Financial to Buy RatingMay 7, 2026 | marketbeat.comHealthcare Momentum Drives Interest In Tactile Systems Technology (NASDAQ:TCMD)May 6, 2026 | kalkinemedia.comKBTIG Keeps Their Buy Rating on Tactile Systems Technology (TCMD)May 6, 2026 | theglobeandmail.comPiper Sandler Sticks to Its Buy Rating for Tactile Systems Technology (TCMD)May 6, 2026 | theglobeandmail.comShould Value Investors Buy Tactile Systems Technology (TCMD) Stock?May 6, 2026 | zacks.comTactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process maturesMay 5, 2026 | msn.comTactile Systems (TCMD) Q1 2026 Earnings TranscriptMay 5, 2026 | finance.yahoo.comBTIG Research Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock PriceMay 5, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCVRX, BBNX, NPCE, and TCMD Company DescriptionsBeta Bionics NASDAQ:BBNX$13.89 +1.44 (+11.57%) Closing price 04:00 PM EasternExtended Trading$13.55 -0.34 (-2.45%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.CVRx NASDAQ:CVRX$5.87 +0.48 (+8.83%) Closing price 03:59 PM EasternExtended Trading$5.82 -0.05 (-0.85%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.NeuroPace NASDAQ:NPCE$16.32 +0.44 (+2.77%) Closing price 04:00 PM EasternExtended Trading$16.16 -0.16 (-1.00%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Tactile Systems Technology NASDAQ:TCMD$25.17 +0.80 (+3.28%) Closing price 04:00 PM EasternExtended Trading$25.90 +0.73 (+2.90%) As of 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand Medtronic Bottoms, Healthy Rebound Ahead From Runway to Riches: Victoria's Secret's New Look Coke's $10B India IPO Plan Pops the Top on Hidden Value Dell's AI Toll Bridge Is Paved with Record Margins The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker GitLab’s Price Recovery Gains Traction—Time to Get On Board? Ulta's Q1 Report Primes It for a Beauty of a Rebound Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
